+1 347 708 0418
The RNA Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global RNA Drugs size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global RNA Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
RNA Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
siRNA
ASO
miRNA
Nucleic Acid Aptamers
Market segment by Application can be divided into
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
The key market players for global RNA Drugs market are listed below:
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe RNA Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of RNA Drugs, with price, sales, revenue and global market share of RNA Drugs from 2019 to 2021.
Chapter 3, the RNA Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the RNA Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and RNA Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe RNA Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 RNA Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global RNA Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 siRNA
1.2.3 ASO
1.2.4 miRNA
1.2.5 Nucleic Acid Aptamers
1.3 Market Analysis by Application
1.3.1 Overview: Global RNA Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Global RNA Drugs Market Size & Forecast
1.4.1 Global RNA Drugs Sales in Value (2016-2026))
1.4.2 Global RNA Drugs Sales in Volume (2016-2026)
1.4.3 Global RNA Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global RNA Drugs Production Capacity Analysis
1.5.1 Global RNA Drugs Total Production Capacity (2016-2026)
1.5.2 Global RNA Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 RNA Drugs Market Drivers
1.6.2 RNA Drugs Market Restraints
1.6.3 RNA Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer RNA Drugs Product and Services
2.1.4 Pfizer RNA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche RNA Drugs Product and Services
2.2.4 Roche RNA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Sanofi-Aventis
2.3.1 Sanofi-Aventis Details
2.3.2 Sanofi-Aventis Major Business
2.3.3 Sanofi-Aventis RNA Drugs Product and Services
2.3.4 Sanofi-Aventis RNA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Abbott Laboratories
2.4.1 Abbott Laboratories Details
2.4.2 Abbott Laboratories Major Business
2.4.3 Abbott Laboratories RNA Drugs Product and Services
2.4.4 Abbott Laboratories RNA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Arrowhead Pharmaceuticals
2.5.1 Arrowhead Pharmaceuticals Details
2.5.2 Arrowhead Pharmaceuticals Major Business
2.5.3 Arrowhead Pharmaceuticals RNA Drugs Product and Services
2.5.4 Arrowhead Pharmaceuticals RNA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Benitec Biopharma
2.6.1 Benitec Biopharma Details
2.6.2 Benitec Biopharma Major Business
2.6.3 Benitec Biopharma RNA Drugs Product and Services
2.6.4 Benitec Biopharma RNA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Calimmune Inc
2.7.1 Calimmune Inc Details
2.7.2 Calimmune Inc Major Business
2.7.3 Calimmune Inc RNA Drugs Product and Services
2.7.4 Calimmune Inc RNA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Dicerna
2.8.1 Dicerna Details
2.8.2 Dicerna Major Business
2.8.3 Dicerna RNA Drugs Product and Services
2.8.4 Dicerna RNA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Gradalis
2.9.1 Gradalis Details
2.9.2 Gradalis Major Business
2.9.3 Gradalis RNA Drugs Product and Services
2.9.4 Gradalis RNA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Quark
2.10.1 Quark Details
2.10.2 Quark Major Business
2.10.3 Quark RNA Drugs Product and Services
2.10.4 Quark RNA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 RXi
2.11.1 RXi Details
2.11.2 RXi Major Business
2.11.3 RXi RNA Drugs Product and Services
2.11.4 RXi RNA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Senesco
2.12.1 Senesco Details
2.12.2 Senesco Major Business
2.12.3 Senesco RNA Drugs Product and Services
2.12.4 Senesco RNA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Silence Therapeutics
2.13.1 Silence Therapeutics Details
2.13.2 Silence Therapeutics Major Business
2.13.3 Silence Therapeutics RNA Drugs Product and Services
2.13.4 Silence Therapeutics RNA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Silenseed
2.14.1 Silenseed Details
2.14.2 Silenseed Major Business
2.14.3 Silenseed RNA Drugs Product and Services
2.14.4 Silenseed RNA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Tekmira
2.15.1 Tekmira Details
2.15.2 Tekmira Major Business
2.15.3 Tekmira RNA Drugs Product and Services
2.15.4 Tekmira RNA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Alnylam Pharmaceuticals
2.16.1 Alnylam Pharmaceuticals Details
2.16.2 Alnylam Pharmaceuticals Major Business
2.16.3 Alnylam Pharmaceuticals RNA Drugs Product and Services
2.16.4 Alnylam Pharmaceuticals RNA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 RNA Drugs Sales by Manufacturer
3.1 Global RNA Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global RNA Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in RNA Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 RNA Drugs Manufacturer Market Share
3.4.2 Top 6 RNA Drugs Manufacturer Market Share
3.5 Global RNA Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and RNA Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global RNA Drugs Market Size by Region
4.1.1 Global RNA Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global RNA Drugs Revenue by Region (2016-2026)
4.2 North America RNA Drugs Revenue (2016-2026)
4.3 Europe RNA Drugs Revenue (2016-2026)
4.4 Asia-Pacific RNA Drugs Revenue (2016-2026)
4.5 South America RNA Drugs Revenue (2016-2026)
4.6 Middle East and Africa RNA Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global RNA Drugs Sales in Volume by Type (2016-2026)
5.2 Global RNA Drugs Revenue by Type (2016-2026)
5.3 Global RNA Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global RNA Drugs Sales in Volume by Application (2016-2026)
6.2 Global RNA Drugs Revenue by Application (2016-2026)
6.3 Global RNA Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America RNA Drugs Sales by Type (2016-2026)
7.2 North America RNA Drugs Sales by Application (2016-2026)
7.3 North America RNA Drugs Market Size by Country
7.3.1 North America RNA Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America RNA Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe RNA Drugs Sales by Type (2016-2026)
8.2 Europe RNA Drugs Sales by Application (2016-2026)
8.3 Europe RNA Drugs Market Size by Country
8.3.1 Europe RNA Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe RNA Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific RNA Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific RNA Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific RNA Drugs Market Size by Region
9.3.1 Asia-Pacific RNA Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific RNA Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America RNA Drugs Sales by Type (2016-2026)
10.2 South America RNA Drugs Sales by Application (2016-2026)
10.3 South America RNA Drugs Market Size by Country
10.3.1 South America RNA Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America RNA Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa RNA Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa RNA Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa RNA Drugs Market Size by Country
11.3.1 Middle East & Africa RNA Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa RNA Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 RNA Drugs Typical Distributors
12.3 RNA Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global RNA Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global RNA Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer RNA Drugs Product and Services
Table 6. Pfizer RNA Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Roche Basic Information, Manufacturing Base and Competitors
Table 8. Roche Major Business
Table 9. Roche RNA Drugs Product and Services
Table 10. Roche RNA Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi-Aventis Major Business
Table 13. Sanofi-Aventis RNA Drugs Product and Services
Table 14. Sanofi-Aventis RNA Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 16. Abbott Laboratories Major Business
Table 17. Abbott Laboratories RNA Drugs Product and Services
Table 18. Abbott Laboratories RNA Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Arrowhead Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Arrowhead Pharmaceuticals Major Business
Table 21. Arrowhead Pharmaceuticals RNA Drugs Product and Services
Table 22. Arrowhead Pharmaceuticals RNA Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Benitec Biopharma Basic Information, Manufacturing Base and Competitors
Table 24. Benitec Biopharma Major Business
Table 25. Benitec Biopharma RNA Drugs Product and Services
Table 26. Benitec Biopharma RNA Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Calimmune Inc Basic Information, Manufacturing Base and Competitors
Table 28. Calimmune Inc Major Business
Table 29. Calimmune Inc RNA Drugs Product and Services
Table 30. Calimmune Inc RNA Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Dicerna Basic Information, Manufacturing Base and Competitors
Table 32. Dicerna Major Business
Table 33. Dicerna RNA Drugs Product and Services
Table 34. Dicerna RNA Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Gradalis Basic Information, Manufacturing Base and Competitors
Table 36. Gradalis Major Business
Table 37. Gradalis RNA Drugs Product and Services
Table 38. Gradalis RNA Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Quark Basic Information, Manufacturing Base and Competitors
Table 40. Quark Major Business
Table 41. Quark RNA Drugs Product and Services
Table 42. Quark RNA Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. RXi Basic Information, Manufacturing Base and Competitors
Table 44. RXi Major Business
Table 45. RXi RNA Drugs Product and Services
Table 46. RXi RNA Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Senesco Basic Information, Manufacturing Base and Competitors
Table 48. Senesco Major Business
Table 49. Senesco RNA Drugs Product and Services
Table 50. Senesco RNA Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Silence Therapeutics Basic Information, Manufacturing Base and Competitors
Table 52. Silence Therapeutics Major Business
Table 53. Silence Therapeutics RNA Drugs Product and Services
Table 54. Silence Therapeutics RNA Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Silenseed Basic Information, Manufacturing Base and Competitors
Table 56. Silenseed Major Business
Table 57. Silenseed RNA Drugs Product and Services
Table 58. Silenseed RNA Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Tekmira Basic Information, Manufacturing Base and Competitors
Table 60. Tekmira Major Business
Table 61. Tekmira RNA Drugs Product and Services
Table 62. Tekmira RNA Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Alnylam Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Alnylam Pharmaceuticals Major Business
Table 65. Alnylam Pharmaceuticals RNA Drugs Product and Services
Table 66. Alnylam Pharmaceuticals RNA Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Global RNA Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 68. Global RNA Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 69. Market Position of Manufacturers in RNA Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 70. Global RNA Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 71. Head Office and RNA Drugs Production Site of Key Manufacturer
Table 72. RNA Drugs New Entrant and Capacity Expansion Plans
Table 73. RNA Drugs Mergers & Acquisitions in the Past Five Years
Table 74. Global RNA Drugs Sales by Region (2016-2021e) & (K Units)
Table 75. Global RNA Drugs Sales by Region (2021-2026) & (K Units)
Table 76. Global RNA Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 77. Global RNA Drugs Revenue by Region (2021-2026) & (USD Million)
Table 78. Global RNA Drugs Sales by Type (2016-2021e) & (K Units)
Table 79. Global RNA Drugs Sales by Type (2021-2026) & (K Units)
Table 80. Global RNA Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 81. Global RNA Drugs Revenue by Type (2021-2026) & (USD Million)
Table 82. Global RNA Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 83. Global RNA Drugs Price by Type (2021-2026) & (USD/Unit)
Table 84. Global RNA Drugs Sales by Application (2016-2021e) & (K Units)
Table 85. Global RNA Drugs Sales by Application (2021-2026) & (K Units)
Table 86. Global RNA Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 87. Global RNA Drugs Revenue by Application (2021-2026) & (USD Million)
Table 88. Global RNA Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 89. Global RNA Drugs Price by Application (2021-2026) & (USD/Unit)
Table 90. North America RNA Drugs Sales by Country (2016-2021e) & (K Units)
Table 91. North America RNA Drugs Sales by Country (2021-2026) & (K Units)
Table 92. North America RNA Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 93. North America RNA Drugs Revenue by Country (2021-2026) & (USD Million)
Table 94. North America RNA Drugs Sales by Type (2016-2021e) & (K Units)
Table 95. North America RNA Drugs Sales by Type (2021-2026) & (K Units)
Table 96. North America RNA Drugs Sales by Application (2016-2021e) & (K Units)
Table 97. North America RNA Drugs Sales by Application (2021-2026) & (K Units)
Table 98. Europe RNA Drugs Sales by Country (2016-2021e) & (K Units)
Table 99. Europe RNA Drugs Sales by Country (2021-2026) & (K Units)
Table 100. Europe RNA Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 101. Europe RNA Drugs Revenue by Country (2021-2026) & (USD Million)
Table 102. Europe RNA Drugs Sales by Type (2016-2021e) & (K Units)
Table 103. Europe RNA Drugs Sales by Type (2021-2026) & (K Units)
Table 104. Europe RNA Drugs Sales by Application (2016-2021e) & (K Units)
Table 105. Europe RNA Drugs Sales by Application (2021-2026) & (K Units)
Table 106. Asia-Pacific RNA Drugs Sales by Region (2016-2021e) & (K Units)
Table 107. Asia-Pacific RNA Drugs Sales by Region (2021-2026) & (K Units)
Table 108. Asia-Pacific RNA Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 109. Asia-Pacific RNA Drugs Revenue by Region (2021-2026) & (USD Million)
Table 110. Asia-Pacific RNA Drugs Sales by Type (2016-2021e) & (K Units)
Table 111. Asia-Pacific RNA Drugs Sales by Type (2021-2026) & (K Units)
Table 112. Asia-Pacific RNA Drugs Sales by Application (2016-2021e) & (K Units)
Table 113. Asia-Pacific RNA Drugs Sales by Application (2021-2026) & (K Units)
Table 114. South America RNA Drugs Sales by Country (2016-2021e) & (K Units)
Table 115. South America RNA Drugs Sales by Country (2021-2026) & (K Units)
Table 116. South America RNA Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 117. South America RNA Drugs Revenue by Country (2021-2026) & (USD Million)
Table 118. South America RNA Drugs Sales by Type (2016-2021e) & (K Units)
Table 119. South America RNA Drugs Sales by Type (2021-2026) & (K Units)
Table 120. South America RNA Drugs Sales by Application (2016-2021e) & (K Units)
Table 121. South America RNA Drugs Sales by Application (2021-2026) & (K Units)
Table 122. Middle East & Africa RNA Drugs Sales by Country (2016-2021e) & (K Units)
Table 123. Middle East & Africa RNA Drugs Sales by Country (2021-2026) & (K Units)
Table 124. Middle East & Africa RNA Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 125. Middle East & Africa RNA Drugs Revenue by Country (2021-2026) & (USD Million)
Table 126. Middle East & Africa RNA Drugs Sales by Type (2016-2021e) & (K Units)
Table 127. Middle East & Africa RNA Drugs Sales by Type (2021-2026) & (K Units)
Table 128. Middle East & Africa RNA Drugs Sales by Application (2016-2021e) & (K Units)
Table 129. Middle East & Africa RNA Drugs Sales by Application (2021-2026) & (K Units)
Table 130. Direct Channel Pros & Cons
Table 131. Indirect Channel Pros & Cons
Table 132. RNA Drugs Typical Distributors
Table 133. RNA Drugs Typical Customers
List of Figures
Figure 1. RNA Drugs Picture
Figure 2. Global RNA Drugs Sales Market Share by Type in 2020
Figure 3. siRNA
Figure 4. ASO
Figure 5. miRNA
Figure 6. Nucleic Acid Aptamers
Figure 7. Global RNA Drugs Sales Market Share by Application in 2020
Figure 8. Cancer
Figure 9. Diabetes
Figure 10. Tuberculosis
Figure 11. Cardiovascular Diseases
Figure 12. Others
Figure 13. Global RNA Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 14. Global RNA Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global RNA Drugs Sales (2016-2026) & (K Units)
Figure 16. Global RNA Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 17. Global RNA Drugs Production Capacity (2016-2026) & (K Units)
Figure 18. Global RNA Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. RNA Drugs Market Drivers
Figure 20. RNA Drugs Market Restraints
Figure 21. RNA Drugs Market Trends
Figure 22. Global RNA Drugs Sales Market Share by Manufacturer in 2020
Figure 23. Global RNA Drugs Revenue Market Share by Manufacturer in 2020
Figure 24. RNA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 RNA Drugs Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 RNA Drugs Manufacturer (Revenue) Market Share in 2020
Figure 27. Global RNA Drugs Sales Market Share by Region (2016-2026)
Figure 28. Global RNA Drugs Revenue Market Share by Region (2016-2026)
Figure 29. North America RNA Drugs Revenue (2016-2026) & (USD Million)
Figure 30. Europe RNA Drugs Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific RNA Drugs Revenue (2016-2026) & (USD Million)
Figure 32. South America RNA Drugs Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa RNA Drugs Revenue (2016-2026) & (USD Million)
Figure 34. Global RNA Drugs Sales Market Share by Type (2016-2026)
Figure 35. Global RNA Drugs Revenue Market Share by Type (2016-2026)
Figure 36. Global RNA Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 37. Global RNA Drugs Sales Market Share by Application (2016-2026)
Figure 38. Global RNA Drugs Revenue Market Share by Application (2016-2026)
Figure 39. Global RNA Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 40. North America RNA Drugs Sales Market Share by Type (2016-2026)
Figure 41. North America RNA Drugs Sales Market Share by Application (2016-2026)
Figure 42. North America RNA Drugs Sales Market Share by Country (2016-2026)
Figure 43. North America RNA Drugs Revenue Market Share by Country (2016-2026)
Figure 44. United States RNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada RNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico RNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe RNA Drugs Sales Market Share by Type (2016-2026)
Figure 48. Europe RNA Drugs Sales Market Share by Application (2016-2026)
Figure 49. Europe RNA Drugs Sales Market Share by Country (2016-2026)
Figure 50. Europe RNA Drugs Revenue Market Share by Country (2016-2026)
Figure 51. Germany RNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France RNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom RNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia RNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy RNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific RNA Drugs Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific RNA Drugs Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific RNA Drugs Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific RNA Drugs Revenue Market Share by Region (2016-2026)
Figure 60. China RNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan RNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea RNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India RNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia RNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia RNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America RNA Drugs Sales Market Share by Type (2016-2026)
Figure 67. South America RNA Drugs Sales Market Share by Application (2016-2026)
Figure 68. South America RNA Drugs Sales Market Share by Country (2016-2026)
Figure 69. South America RNA Drugs Revenue Market Share by Country (2016-2026)
Figure 70. Brazil RNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina RNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa RNA Drugs Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa RNA Drugs Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa RNA Drugs Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa RNA Drugs Revenue Market Share by Country (2016-2026)
Figure 76. Turkey RNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt RNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia RNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa RNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
Buy
